AV网站国产不卡|a阿V天堂亚洲阿∨天堂在线|a在线视频播放免费视|yy717午夜福利

<sup id="zd4np"></sup>

array(25) {
  ["id"]=>
  string(5) "75068"
  ["name"]=>
  string(16) "唐熠達(dá)MD, PhD"
  ["avatar"]=>
  string(69) "https://img.39yst.com/uploads/55/f4ddb4a6812cfda9b2780a35e8347142.jpg"
  ["status"]=>
  string(1) "0"
  ["rank_type"]=>
  string(1) "5"
  ["duodian_main_id"]=>
  string(1) "0"
  ["miaopai"]=>
  string(0) ""
  ["graphic_consult"]=>
  string(1) "0"
  ["position"]=>
  string(6) "教授"
  ["introduction"]=>
  string(11546) "北京大學(xué)第三醫(yī)院副院長(zhǎng)北京大學(xué)第三醫(yī)院血管醫(yī)學(xué)研究所所長(zhǎng)血管穩(wěn)態(tài)與重構(gòu)全國(guó)重點(diǎn)實(shí)驗(yàn)室副主任北京大學(xué)人工智能研究院智慧醫(yī)療與康養(yǎng)中心主任唐熠達(dá)，教授、主任醫(yī)師，博士研究生導(dǎo)師?，F(xiàn)任北京大學(xué)第三醫(yī)院科研副院長(zhǎng)、血管醫(yī)學(xué)研究所常務(wù)副所長(zhǎng)、醫(yī)學(xué)創(chuàng)新研究院副院長(zhǎng)。享受國(guó)務(wù)院政府特殊津貼，國(guó)家杰出青年科學(xué)基金獲得者，國(guó)家百千萬人才工程“有突出貢獻(xiàn)中青年專家”，教育部長(zhǎng)江學(xué)者特聘教授，首都科技領(lǐng)軍人才。長(zhǎng)期從事心血管疾病危重癥如心力衰竭和心肌梗死的復(fù)合治療及冠心病高危復(fù)雜病變的介入治療；致力于心臟瓣膜病的微創(chuàng)介入治療和內(nèi)外科一站式復(fù)合手術(shù)；拓展和推動(dòng)心血管疾病合并代謝紊亂的規(guī)范化和個(gè)體化診療。作為項(xiàng)目負(fù)責(zé)人先后主持多項(xiàng)重大國(guó)家級(jí)和省部級(jí)科研項(xiàng)目，如“十二五”、“十三五”國(guó)家科技支撐計(jì)劃、973項(xiàng)目子課題、國(guó)家杰出青年科學(xué)基金、國(guó)自然重大研究計(jì)劃、首都臨床特色應(yīng)用研究重點(diǎn)課題等；牽頭組織多項(xiàng)多中心大規(guī)模臨床研究。致力于心血管領(lǐng)域的創(chuàng)新藥物和醫(yī)療器械的研發(fā)，獲得多項(xiàng)國(guó)家發(fā)明專利和軟件著作權(quán)，發(fā)表一系列高水平文章，主編多部專著。任分子心血管學(xué)教育部重點(diǎn)實(shí)驗(yàn)室副主任，中華醫(yī)學(xué)會(huì)心血管病分會(huì)全國(guó)委員/代謝性心血管疾病學(xué)組組長(zhǎng)，中國(guó)醫(yī)療器械行業(yè)協(xié)會(huì)臨床試驗(yàn)分會(huì)副主任委員，海峽兩岸醫(yī)藥衛(wèi)生交流協(xié)會(huì)心血管專業(yè)委員會(huì)候任主任委員，北京醫(yī)學(xué)會(huì)心血管分會(huì)副主任委員等。教育經(jīng)歷:管理學(xué)碩士, 美國(guó)約翰霍普金斯大學(xué), ?2014.9-2017.7博士，北京協(xié)和醫(yī)學(xué)院, 2000.9-2003.7		碩士，北京協(xié)和醫(yī)學(xué)院，1997.9-2000.7	學(xué)士，湖南醫(yī)科大學(xué) (現(xiàn)中南大學(xué)湘雅醫(yī)學(xué)院) 1990.7-1995.6工作經(jīng)歷：2020/09 至今 		教授，主任醫(yī)師，北京大學(xué)第三醫(yī)院2008/06 -2020/08 ?	主任醫(yī)師，中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院2005/06 -2008/05 ?	博士后、副研究員，美國(guó)耶魯大學(xué)醫(yī)學(xué)院心臟內(nèi)科2004/06 -2005/06 ?	博士后，美國(guó)南達(dá)科他大學(xué)心臟病研究所1995/09 -2004/05 ?	主治醫(yī)師、總住院醫(yī)師、住院醫(yī)師，中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院Yi-Da Tang, MD, PhDProfessor, Vice PresidentPeking University Third HospitalDirector, Institute of Vascular Medicine, Peking University Third HospitalDeputy Director, State Key Laboratory of Vascular Homeostasis and RemodelingDirector, Innovative Healthcare and Wellness Research Center, Institute for Artificial IntelligenceDr. Yi-Da Tang, an interventional cardiologist and scientist, specializes in the clinical diagnosis and treatment of complex coronary artery disease and structural heart diseases. His bench-to-bedside research focuses on studying the pathophysiological mechanisms underlying thyroid dysfunction and myocardial infarction, heart failure, and valvular heart disease, identifying key pathogenic driver of dyslipidemia and atherosclerosis, as well as the prevention of cardiometabolic diseases, such as those with hyperlipidemia, chronic kidney diseases, and thyroid dysfunctions.Dr. Tang has led a series of pioneering randomized controlled trials on pharmacological therapies for thyroid dysfunction in patients with heart failure and myocardial infarction, as well as novel drug targets for hyperlipidemia. Additionally, he has optimized antithrombotic strategies for high-risk patients after percutaneous coronary intervention and pioneered hybrid surgeries for coronary artery disease combined with aortic dissection.Dr. Tang also leads collaborative research focusing on artificial intelligence (AI)-facilitated medical applications. His team has developed the "MediGuide" large language model to enhance the triage and early diagnosis of myocardial infarction and heart failure with preserved ejection fraction (HFpEF) stratification, aiming to improve early warning for cardiovascular emergencies, enhancing prediction accuracy and reducing the diagnostic window.EducationMBA, Johns Hopkins University, USA, 2017MD, Clinical Medicine, Peking Union Medical College, 2003Master, Clinical Medicine, Peking Union Medical College, 2000Bachelor, Clinical Medicine, Xiangya School of Medicine of Central South University, 1995Research Positions2020/09 to Current	Chief physician, Peking University Third Hospital 2008/06 -2020/08	Chief physician, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College2005/06 -2008/05	Assistant professor, Postdoctoral research fellow, Yale University School of Medicine, Department of Cardiology2004/06 -2005/06	Postdoctoral research fellow, University of South Dakota, Cardiovascular Research Institute 1995/09 -2004/05	Attending Physician, Chief Resident, Resident, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegePublications1.	Chen Li, Chuangshi Wang, Jun Hao, Yitian Zheng, Jie Yang, Wenyao Wang, Yi-Da Tang, Level of evidence supporting the Chinese cardiovascular disease clinical practice guidelines and its evolution in the past two decades, The Lancet Regional Health - Western Pacific, 2023, 100773. (IF =7.1)2.	Zhou Q, Yang J, Tang H, Guo Z, Dong W, Wang Y, Meng X, Zhang K, Wang W, Shao C, Hua X, Tang YD. High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction. Cardiovasc Diabetol. 2023 Sep 29;22(1):263. (IF =9.3)3.	Zhou Q, Yang J, Wang W, Shao C, Hua X, Tang YD.	The impact of the stress hyperglycemia ratio on mortality and rehospitalization rate in patients with acute decompensated heart failure and diabetes. Cardiovasc Diabetol. 2023 Jul 26;22(1):189. (IF =9.3)4.	Xiong YJ, Du LL, Diao YL, Wen J, Meng XB, Gao J, Shao CL, Wang WY, Zhu XY, Tang YD. Association of dietary inflammatory index with helicobacter pylori infection and mortality among US population. J Transl Med. 2023 Aug 12;21(1):538. (IF =7.4)5.	Yang J, Wang Y, Xi Z, Ma Y, Shao C, Wang W, Tang Y-D. Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis. Journal of Cardiovascular Development and Disease. 2022; 9(12):452.(IF =4.415)6.	Jie Yang, Yitian Zheng, Chen Li, Jun Gao, Xiangbin Meng, Kuo Zhang, Wenyao Wang, Chunli Shao, Yi-Da Tang#. The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with acute coronary syndrome：Insight from a large cohort study in Asia Running title: Association of SHR with cardiovascular prognosis. Diabetes Care, 2022; 45 (4): 947–956. (IF =17.152)7.	Dong C, Yang Y, Wang Y, Hu X, Wang Q, Gao F, Tang YD#. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease. ?J Adv Res. 2022. (IF=12.822)8.	Zheng, Y., Li, C., Yang, J. Tang YD#. Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China. Cardiovasc Diabetol. 2022; 21: 29. (IF=8.949)9.	Jie Yang, Yitian Zheng, Chen Li, Yu Peng Liu, Qing Zhou, Jun Gao, Xiangbin Meng, Kuo Zhang, Wenyao Wang, Chunli Shao, Yi-Da Tang#. The impact of subclinical hyperthyroidism on cardiovascular prognosis in patients undergoing percutaneous coronary intervention. The Journal of Clinical Endocrinology & Metabolism, 2021, 4: 4. (IF =5.898)10.	Zimin Song, Ruotong Yang, Wenxiu Wang, Ninghao Huang, Zhenhuang Zhuang, Yuting Han, Lu Qi, Ming Xu, Yi-da Tang#, Tao Huang#. Association of healthy lifestyle including a healthy sleep pattern with incident type 2 diabetes mellitus among individuals with hypertension. Cardiovascular Diabetology, 2021; 20:239. (IF =8.949)11.	Yupeng Liu, Jingjing Song, Juan Yang, Jilin Zheng, Ling Yang, Jun Gao, Song Tian, Zhen Liu, Xiangbin Meng, Jian-Cheng Wang, Zhifei Dai, Yi-Da Tang#. ?Tumor necrosis factor-α-induced protein 8-like 2 alleviates nonalcoholic fatty liver disease via suppressing TAK1 activation. Hepatology. 2021; 74: 1300-1318.(IF=17.425)12.	Jingjing Song, Yupeng Liu, Juan Wan, Guang-Nian Zhao, Jian-Cheng Wang, Zhifei Dai, Sha Hu, Ling Yang, Zhen Liu, Yi Fu, Erdan Dong, Yi-Da Tang#. SIMPLE is an endosomal regulator that protects against NAFLD by targeting the lysosomal degradation of EGFR. Hepatology. 2021;74:3091-3109.(IF=17.425) 13.	Liu Y, Wang W, Song J, Zhang K, Tang YD#. Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention. International Journal of Cardiology.2021;333:60-68.(IF=4.164)14.	Xie M, Tang Y and Hill JA. HDAC inhibition as a therapeutic strategy in myocardial ischemia/reperfusion injury. J Mol Cell Cardiol. 2019;129:188-192. (IF=5.296)15.	Zhang X, Wang WY, Zhang K, Tian J, Zheng JL, Chen J, An SM, Wang SY, Liu YP, Zhao Y, Wang JJ, Yang M and Tang YD#. Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF). Trials. 2019;20:143.（IF=2.067）16.	Tang YD#*, Wang W, Yang M, Zhang K, Chen J, Qiao S, Yan H, Wu Y, Huang X, Xu B, Gao R, Yang Y and Investigators C. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial. Circulation. 2018;137:2231-2245. (IF=29.69)17.	Wang S, Yan ZZ, Yang X, An S, Zhang K, Qi Y, Zheng J, Ji YX, Wang PX, Fang C, Zhu XY, Shen LJ, Yan FJ, Bao R, Tian S, She ZG and Tang YD#. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. Hepatology. 2018;67:1320-1338. (IF=17.425)18.	Sun P, Zeng Q, Cheng D, Zhang K, Zheng J, Liu Y, Yuan YF and Tang YD#. ?Caspase Recruitment Domain Protein 6 protects against hepatic steatosis and insulin resistance by suppressing Ask1. Hepatology. 2018;68:2212-2229.(IF=17.425)19.	Sun P, Lu YX, Cheng D, Zhang K, Zheng J, Liu Y, Wang X, Yuan YF and Tang YD#. ?Monocyte chemoattractant protein-induced protein 1 targets hypoxia-inducible factor 1alpha to protect against hepatic ischemia/reperfusion injury. Hepatology. 2018;68:2359-2375. ((IF=17.425)20.	Tang Y*, Qiao S, Su X, Chen Y, Jin Z, Chen H, Xu B, Kong X, Pang W, Liu Y, Yu Z, Li X, Li H, Zhao Y, Wang Y, Li W, Tian J, Guan C, Xu B and Gao R. Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial. JACC Cardiovasc Interv. 2018;11:2381-2392. (IF=9.544)21.	An S, Zhao LP, Shen LJ, Wang S, Zhang K, Qi Y, Zheng J, Zhang XJ, Zhu XY, Bao R, Yang L, Lu YX, She ZG and Tang YD#. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity. Hepatology. 2017;66:1866-1884.(IF=17.425)22.	Tang YD* and Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006;113:2454-61.(IF=29.69)23.	Tang YD*, Kuzman JA, Said S, Anderson BE, Wang X and Gerdes AM. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation. 2005;112:3122-30. (IF=29.69)"
  ["adept"]=>
  string(557) "擅長(zhǎng)心血管疾病危重癥、急慢性心力衰竭、瓣膜性心臟病以及心血管代謝疾病(合并糖尿病、高脂血癥、高尿酸血癥、 甲狀腺功能異常的心血管疾病)的診斷和治療；復(fù)雜冠心病和瓣膜性心臟病的評(píng)估診斷和藥物、介入治療; 冠心病復(fù)雜病變(包括 CTO 慢性完全閉塞、左主干、高難度分叉病變等)的介入治療(包括旋磨、支架、藥物球囊、內(nèi)外科一站式復(fù)合雜交手術(shù)等)；高脂血癥（包括家族性高膽固醇血癥）的血液凈化治療。"
  ["duodian_doctor_id"]=>
  string(6) "110453"
  ["source_from"]=>
  string(12) "醫(yī)院官網(wǎng)"
  ["is_jingxuan"]=>
  string(1) "0"
  ["title_num"]=>
  string(0) ""
  ["created"]=>
  string(10) "1754462992"
  ["doctor_title"]=>
  string(6) "教授"
  ["is_seniority"]=>
  int(1)
  ["province_id"]=>
  int(0)
  ["city_id"]=>
  int(0)
  ["hospital_sort"]=>
  string(2) "12"
  ["hospital"]=>
  array(1) {
    [0]=>
    array(31) {
      ["id"]=>
      string(2) "55"
      ["name"]=>
      string(24) "北京大學(xué)第三醫(yī)院"
      ["grade_id"]=>
      string(1) "2"
      ["grade"]=>
      string(6) "三甲"
      ["type"]=>
      string(1) "1"
      ["duodian_hospital_id"]=>
      string(3) "100"
      ["address"]=>
      string(35) "北京市海淀區(qū)花園北路49號(hào)"
      ["is_gongli"]=>
      string(1) "1"
      ["logo"]=>
      string(72) "http://pic.39yst.com/group2/M00/89/7A/Co2PPWGoZcGAcHxDAAAkGKJfo6I192.png"
      ["is_pay"]=>
      string(1) "0"
      ["pic"]=>
      string(73) "https://pic.39yst.com/group1/M00/04/54/Co0f9VoqRXOAQGRnAAJ8PAioNOA535.jpg"
      ["is_top100"]=>
      string(1) "1"
      ["parent_areaid"]=>
      string(1) "1"
      ["areaid"]=>
      string(4) "2800"
      ["top100_sort"]=>
      string(2) "12"
      ["guide"]=>
      string(0) ""
      ["tel"]=>
      string(43) "010-82266699(總機(jī))，010-82266688(總機(jī))"
      ["is_seniority"]=>
      string(1) "1"
      ["hospital_title"]=>
      string(6) "三甲"
      ["hospital_grade_id"]=>
      string(1) "2"
      ["hospital_type"]=>
      string(12) "綜合醫(yī)院"
      ["hospital_type_id"]=>
      string(1) "1"
      ["hospital"]=>
      string(24) "北京大學(xué)第三醫(yī)院"
      ["department_id"]=>
      string(2) "18"
      ["duodian_department_id"]=>
      string(5) "83573"
      ["duodian_department_pid"]=>
      string(5) "83555"
      ["department_name"]=>
      string(15) "心血管內(nèi)科"
      ["standard_department_id"]=>
      string(2) "18"
      ["parent_standard_department_id"]=>
      string(1) "7"
      ["hospital_department"]=>
      string(15) "心血管內(nèi)科"
      ["duty"]=>
      array(0) {
      }
    }
  }
  ["version"]=>
  int(40)
  ["isHaveSource"]=>
  int(0)
  ["duty"]=>
  string(0) ""
}